http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2019010085-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b42dc77f7e97aa82cb8c811f02278cf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
filingDate 2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e724de063382311dc73b0f047efbda0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0393b52076d35931031fdd42ce19d123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ac81965d66794449e563158b34be668
publicationDate 2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2019010085-A
titleOfInvention SULFOXIMINE GLYCOSIDASE INHIBITORS.
abstract The compounds of formula (I): (see Formula) where A, R, W, Q, n and m have the meaning according to the claims, can be used, among other things, for the treatment of tauopathies and Alzheimer disease.
priorityDate 2017-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139610

Total number of triples: 25.